Benitec Biopharma Limited Net Debt/EBITDA

Net Debt/EBITDA of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt/EBITDA growth rates and interactive chart.


Highlights and Quick Summary

  • Net Debt/EBITDA for the quarter ending June 30, 2022 was 0.74 (a -67.96% decrease compared to previous quarter)
  • Year-over-year quarterly Net Debt/EBITDA decreased by -76.25%
  • Annual Net Debt/EBITDA for 2022 was 0.2 (a -86.57% decrease from previous year)
  • Annual Net Debt/EBITDA for 2021 was 1.48 (a -0.3% decrease from previous year)
  • Annual Net Debt/EBITDA for 2021 was 1.48 (a 25.29% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt/EBITDA of Benitec Biopharma Limited

Most recent Net Debt/EBITDAof BNTC including historical data for past 10 years.

Interactive Chart of Net Debt/EBITDA of Benitec Biopharma Limited

Benitec Biopharma Limited Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.74 2.32 0.2
2021 2.42 3.13 5.21 3.19 1.48
2020 4.29 2.68 3.36 5.31 1.19
2019 6.37 0.0 -5.73
2018 1.42
2017 5.24 3.21
2016 -13.53 0.0 0.0 0.86
2015 0.0 0.0 2.11
2014 0.0 0.0 4.26
2013 0.0 0.46

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology